Tempus AI's main products and services are divided into advanced diagnostic testing and data-driven analytical solutions. Its diagnostic portfolio includes specialized genomic sequencing assays, hereditary cancer panels, and molecular testing kits utilized by physicians to personalize oncology treatments. Additionally, the company offers data licensing platforms, artificial intelligence modeling tools, and clinical trial matching software designed to help pharmaceutical researchers discover new therapies and optimize clinical workflows.